Last edition
News about "Drugs Controller General of India (DCGI)"
India Now Among Top Global Reporters of Drug Adverse Events, Says DCGI
India has emerged as one of the top global contributors in reporting adverse drug events, according to Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI). He made the remarks during the inauguration of the 5th National Pharmacovigilance Week in New Delhi.
Drugs Controller General Of India (DCGI) | 18/09/2025 | By Darshana
Monitor NDMA Impurity in Ranitidine Formulation: DCGI Directs Indian Drugmakers
The DCGI has instructed drug controllers of all States and Union Territories to ensure that manufacturers under their jurisdiction monitor the presence of N-Nitrosodimethylamine(NDMA) - a potentially carcinogenic impurity – in the active pharmaceutical ingredient (API) and formulation of the antacid Ranitidine.
Drugs Controller General Of India (DCGI) | 31/07/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy